Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 ...

Pre-earnings options volume in LifeMD (LFMD) is 5.6x normal with calls leading puts 22:1. Implied volatility suggests the market is anticipating a ...

LifeMD reported a fourth-quarter loss per share of 2 cents. Analysts were expecting a loss of 5 cents per share, according to FactSet. Revenue for the fourth quarter came in at $64.3 million. Analysts ...

Reports Q4 revenue $64.3M, consensus $57.4M. “LifeMD (LFMD) had a great fourth quarter. We not only achieved record quarterly revenue and ...

LifeMD Inc (LFMD)公布2024年第四季度业绩强劲,每股收益 (EPS)达到$0.21,远超预期亏损$0.05。公司收入达到$64.3百万,超过预期的$57.66百万。财报公布后,LifeMD股价在盘后交易中上涨19.44%,收于$5.10。

Tenon Medical received notice of two approvals from the European patent office. The medical-device maker after the bell said two additional patents related to its Catamaran Sacroiliac Joint Fixation ...

纽约 - 虚拟初级保健服务提供商LifeMD, Inc. (NASDAQ: LFMD )股价上涨16%，此前该公司发布的第四季度财报超出分析师预期，并提供了强劲的2025年业绩指引。 公司报告调整后每股收益为$0.21，较分析师预期的-$0.05高出$0.26。季度营收达到$64.3 million，同比增长43%，超过市场普遍预期的$57.66 million。

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.12 per share a year ago. These figures are ...

M.Optimize Your Investment Research with SparkEffectively assess a stock's risks and opportunities with a clear ...

LifeMD Inc (NASDAQ:LFMD) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.